News & Views | Published:

Hepatitis C

Should antiviral therapy be offered to elderly patients?

Nature Reviews Gastroenterology & Hepatology volume 6, pages 503504 (2009) | Download Citation

Relatively little information exists on the prognosis for elderly patients with chronic hepatitis C (CHC). Moreover, the majority of randomized, clinical trials of hepatitis C treatment exclude elderly patients. Findings from a 2009 clinical study address risk of hepatocellular carcinoma, life expectancy and the influence of antiviral therapy in elderly patients with CHC.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    et al. Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C? J. Am. Geriatr. Soc. 54, 549–550 (2006).

  2. 2.

    , et al. Necessities of interferon therapy in elderly patients with chronic hepatitis C. Am. J. Med. 122, 479–486, (2009).

  3. 3.

    et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann. Intern. Med. 144, 705–714 (2006).

  4. 4.

    , & National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population. Intervirology 49, 7–17 (2006).

  5. 5.

    Prevention of hepatitis C-virus related hepatocellular carcinoma. Gastroenterology 127 (Suppl. 1), S294–S302 (2004).

  6. 6.

    Hot topics in hepatitis C virus treatment: Recommendations from an AISF/SIMID/SIMAST Expert Opinion Meeting [], (2009).

  7. 7.

    et al. Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease? Am. J. Gastroenterol. 101, 1260–1267 (2006).

  8. 8.

    et al. Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C. Hepatology 43, 54–63 (2006).

  9. 9.

    & Viral hepatitis in older adults. J. Am. Geriatr. Soc. 45, 755–763 (1997).

Download references

Author information


  1. Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy.

    • Annarosa Floreani


  1. Search for Annarosa Floreani in:

Competing interests

The author declares no competing financial interests.

Corresponding author

Correspondence to Annarosa Floreani.

About this article

Publication history



Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing